Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Creams: SOP for Allergen Testing in Cream Products – V 2.0

Posted on By

Creams: SOP for Allergen Testing in Cream Products – V 2.0

Standard Operating Procedure for Allergen Testing in Cream Products

Department Creams
SOP No. SOP/CRM/143/2025
Supersedes SOP/CRM/143/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for allergen testing in cream products. Allergens present in cosmetics can cause allergic reactions, making their presence and concentration a significant safety concern. This SOP ensures that cream products are tested for common allergens to meet regulatory standards and protect consumer health.

2. Scope

This SOP applies to all cream formulations produced at the facility, especially those intended for direct consumer use. It includes procedures for testing the cream products for the presence of allergens during the production process and before the final product release.

3. Responsibilities

  • Production Team: Responsible for ensuring that cream formulations are prepared in compliance with allergen safety guidelines and for ensuring that all ingredients used are compliant with allergen testing standards.
  • Quality Control (QC) Team: Responsible for conducting allergen testing and ensuring that the test results meet the regulatory and internal specifications for allergen content.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the
results of allergen testing to ensure compliance with internal specifications and regulatory requirements.

4. Accountability

The QC Manager is accountable for ensuring that allergen testing is performed in accordance with this SOP. The Production Supervisor is responsible for ensuring that the cream formulations are produced according to allergen safety guidelines. The QA Manager ensures that the test results are reviewed and approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary equipment for allergen testing is available, including suitable test kits (e.g., ELISA kits) and a properly calibrated laboratory balance for sample preparation.
  2. Prepare the necessary reagents and calibration standards according to the testing method. Use certified reference materials (CRMs) for allergen calibration.
  3. Review the batch record to confirm the formulation details, including the ingredients used, and identify potential allergens that need to be tested for.

5.2 Sample Collection

  1. Collect a representative sample of the finished cream product. Ensure the sample is homogeneous and free from contamination.
  2. Label each sample with the batch number, sample ID, sampling date, and other relevant details to ensure traceability during testing.
  3. Ensure that the sample is taken from sealed containers to maintain the integrity of the formulation and prevent cross-contamination during testing.

5.3 Allergen Testing Procedure

  1. Prepare the sample for allergen testing by following the manufacturer’s instructions for the specific test method (e.g., ELISA or PCR for allergens such as peanuts, tree nuts, dairy, gluten, etc.).
  2. Perform the allergen test in triplicate to ensure consistency and reliability of the results. The sample should be prepared and tested under controlled conditions to avoid contamination.
  3. Record the allergen content results for each test sample, noting the concentration of each allergen tested, in the Allergen Testing Log (Annexure-1).

5.4 Interpretation of Results

  1. Compare the allergen test results with the specified limits for each allergen. The permissible levels for allergens are typically defined by regulatory agencies (e.g., FDA, EMA) and should be within the thresholds established for consumer safety.
  2. For example, the FDA recommends that the maximum allowable concentration for peanuts or other allergens in cosmetics should be non-detectable or below the threshold level for allergic reactions.
  3. If the test results show that the allergen concentration is within the acceptable range, mark the test as “Pass” in the Allergen Testing Log (Annexure-1) and proceed with the next stage of production or release.
  4. If the test results show that the allergen concentration exceeds the specified limit, mark the test as “Fail.” Investigate the source of the contamination, which may include ingredients, equipment contamination, or cross-contamination during production.

5.5 Post-Test Activities

  1. Record all test results, including batch number, sample ID, allergen concentrations, and any corrective actions taken, in the Allergen Testing Log (Annexure-1).
  2. If the allergen test fails, initiate corrective actions such as revisiting the sourcing of ingredients, revising the formulation, or improving production processes to ensure that allergens are minimized or removed. Re-test the sample after corrective actions.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.6 Documentation and Record-Keeping

  1. Ensure that all allergen testing records are complete, accurate, and securely stored. This includes the Allergen Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • ELISA: Enzyme-Linked Immunosorbent Assay

7. Documents

  1. Annexure-1: Allergen Testing Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • FDA Guidelines for Allergen Testing in Cosmetics
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Allergen Testing Log

Batch Number Sample ID Test Date Allergen Concentration (ppm) Operator
12345 S-001 21/01/2026 Peanuts: 0 ppm, Gluten: 0.2 ppm John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Gluten content exceeded permissible limits Re-sourced raw material, reprocessed the batch Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
See also  Creams: SOP for Dispensing Cream Batches into Intermediate Storage - V 2.0
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: BA-BE Studies: SOP for Maintaining Source Data Verification Logs – V 2.0
Next Post: Biosimilars: SOP for Data Integrity in CLD Operations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version